Joint Programming AMR Intergovernmental Workshop Initiative on - - PowerPoint PPT Presentation

Joint Programming Initiative on Antimicrobial Resistance

AMR Intergovernmental Workshop Paris, 17 November, 2015 Mats Ulfendahl

Chair JPIAMR

www.jpiamr.eu

www.jpiamr.eu

• Why joint programming
• JPIAMR today
• Activities
• Concept

Why Joint Programming? Addressing the grand challenges Establishing the ERA – “a European research area in which researchers, scientific knowledge and technology circulate freely, and encouraging it to become more competitive…” */

*/ From the Treaty on the Functioning of the European Union

Global!

www.jpiamr.eu

Antibiotic resistance: ”One of the Greatest Threats to Public Health“

www.jpiamr.eu

www.jpiamr.eu

A major societal challenge requiring joint and coordinated actions

Global challenges need global solutions “Without a coordinated global response, humanity will not overcome the challenges it faces.“

(Subra Suresh, Nature 2012)

About JPIAMR

The Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) joins forces across nations to fight AMR through effective collaborative actions in areas of unmet needs.

www.jpiamr.eu

JPIAMR’s added value

• World-wide cooperation to align international

resources to enable joint actions in areas of unmet needs.

• A platform to take AMR combat from

awareness to action.

• Supporting international research and facilitating

its translation to industry and policy.

• Shared common strategic research agenda to

align national priorities and coordinated actions

www.jpiamr.eu

Strategic Research Agenda

• Scientific Advisory Board
• National expert panels
• Online consultation
• Stakeholder involvement

Working together

22 countries to date have joined forces to define a common vision, a strategic research agenda and joint planning as well as implementation of national research programmes

• Argentina
• Canada
• Belgium
• Czech Republic
• Denmark
• Estonia
• Finland
• France
• Germany
• Greece
• Israel
• Italy
• Japan
• the Netherlands
• Norway
• Poland

www.jpiamr.eu

• Romania
• Spain
• Sweden
• Switzerland
• Turkey
• United Kingdom

• 1. Mapping the AMR landscape
• 2. Developing International Collaboration
• 3. Exploratory / Scoping workshops
• 4. Calls for Research Proposals
• 5. Alignment of Research Programs

Implementing the Strategic Research Agenda 2015-2017

www.jpiamr.eu

• 1. Mapping the AMR research landscape

A mapping exercise and gap analysis to find scale and scope

• f research activities and creating frameworks of evaluation.

The research database is public and can be found on www.jpiamr.eu

www.jpiamr.eu Funding source Total no of projects (2007- 2013) Total funding (EUR) % of total funding % of total funding incl EC and IMI 19 JPIAMR countries 1,129 646,646,541 67.3% 49.5% EC 105 314,072,980 32.7% 50.5% IMI 9 345,128,438

• Overall

1,234 1,305,847,959 100% 100%

www.jpiamr.eu

5% 3% 15% 3% 11% 63%

National projects

Interventions Environment Transmission Surveillance Diagnostics Therapeutics

• 1. Mapping the AMR research landscape

www.jpiamr.eu

8% 3% 14% 12% 10% 53%

EC and IMI projects

Interventions Environment Transmission Surveillance Diagnostics Therapeutics

• 1. Mapping the AMR research landscape

• 2. Developing International Collaboration

www.jpiamr.eu

For example,

• DG RTD (Research & Innovation)
• The World Health Organisation (WHO)
• Joint Industry Group EC-JPI-IMI-EFPIA
• DG Santé
• Partnerships outside Europe

For example:

• Diagnostics
• Research Infrastructures
• Transmission Dynamics

www.jpiamr.eu

• 3. Exploratory/scoping workshops
• To bring together experts from diverse fields
• To identify future joint actions
• To identify knowledge gaps

• Annual Joint Calls with national funding

agencies

www.jpiamr.eu

• 4. Calls for Research Proposals

One example: Innovative approaches to address antibacterial resistance

– 14 funding agencies from 12 countries with a total budget of 13.8M€ – Projects covered areas within prevention of infection, therapy, drug development, target identification, and pharmacokinetics

“The possibility to complement our expertise with

• ther research groups made our proposal so much

stronger.”

Mariel Pickermann, PI of REBEL, a JPIAMR funded project looking at restoring the antibacterial activity of β-lactam antibiotic.

www.jpiamr.eu

• 4. Calls for Research Proposals

• For example:

– Mapping National Plans – Mapping Research Programs – Aligning national plans/programs with the SRA – Identifying areas around the SRA to syncronise/align national calls

www.jpiamr.eu

• 5. Alignment of Research Programs

www.jpiamr.eu

JPIAMR Concept

Ideas Support Actions  Results

Get member state commitment and support! Involve and commit the research community!

Thank you for your attention!

More information: www.jpiamr.eu Contacts: mats.ulfendahl@vr.se secretariat.jpiamr@vr.se

www.jpiamr.eu